Practical Fragments

This blog is meant to allow Fragment-based Drug Design Practitioners to get together and discuss NON-CONFIDENTIAL issues regarding fragments.

Showing posts with label AstraZeneca. Show all posts
Showing posts with label AstraZeneca. Show all posts
13 May 2015

When Fragments don't deliver...

›
In the olden days (1980s), during the cold war, Russia was "a riddle wrapped in a mystery inside an enigma".  Kremlin Watching w...
1 comment:
21 October 2014

Benchmark Your Process

›
So, not everybody agrees with me on what a fragment is .  As has been pointed out years ago, FBDD can be a FADD .  In this paper , from ea...
10 comments:
29 January 2014

Kill Them Bugs!

›
Bugs are bad.  I hate bugs.  Bugs of all kinds.  In our part of the world we have a particularly noxious, invasive bug called the stink bug...
1 comment:
14 April 2013

Fragments in the clinic: AZD5363

›
As illustrated earlier this year , kinases have been a fertile field for fragments. In a recent issue of J. Med. Chem. , Jason Kettle and co...
23 April 2011

Ligandability

›
The sequencing of the human genome has thrown up lots of potential targets, but choosing which ones to pursue is difficult: many are not bio...
2 comments:
›
Home
View web version
Powered by Blogger.